IP Library Granted Patent US 9,365,826
Granted Patent B2
US 9,365,826 · App. 13/164,461 · Granted Jun 14, 2016

Cardiomyocyte medium with dialyzed serum

Inventors: Nathan Meyer (Mazomanie, WI); Brad Swanson (Waunakee, WI); Steve Fiene (Middleton, WI)
Assignee: Cellular Dynamics International, Inc.
C12N5/0657C12N2500/00C12N2501/999
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,365,826
App. No.
13/164,461
Granted
Jun 14, 2016
Kind
B2
Abstract

Methods and composition for maintenance of cardiomyocytes are provided. For example, in certain aspects methods including culturing the cardiomyocytes in a medium essentially free of serum or containing dialyzed serum to maintain long-term purity. In further aspects, methods for modulation of cardiomyocytes may be provided.

Claims (15)

1. A composition comprising a cell population of at least 90% cardiomyocytes and a medium that is essentially free of glucose, wherein said cardiomyocytes are prepared from human induced pluripotent stem (iPS) cells and further wherein said cells have been cultured in said medium for at least 7 days.

2. The composition of claim 1 , wherein the medium comprises dialyzed serum.

3. The composition of claim 2 , wherein the medium comprises dialyzed serum in a range of about 1% to about 75%.

4. The composition of claim 3 , wherein the medium comprises dialyzed serum of at least 10%.

5. The composition of claim 4 , wherein the medium comprises dialyzed serum of at least 25%.

6. The composition of claim 4 , wherein the medium comprises dialyzed serum of about 55%.

7. The composition of claim 2 , wherein said serum has been treated to remove low molecular weight molecules having a molecular weight of at most 10 kD.

8. The composition of claim 2 , wherein said serum is essentially free of low molecular weight molecules having a molecular weight of at most 10 kD.

9. The composition of claim 1 , wherein the medium does not comprise glucose.

10. The composition of claim 1 , wherein the medium comprises about 1 to 20 mM galactose.

11. The composition of claim 1 , wherein the medium comprises about 0.1 to 10 mM pyruvate or pyruvic acid.

12. The composition of claim 1 , wherein the composition comprises a cell population of at least 95% cardiomyocytes.

13. The composition of claim 1 , wherein the cardiomyocytes express at least one selectable or screenable transgene under the control of a cardiomyocyte-specific promoter.

14. The composition of claim 1 , wherein the population is essentially free of fibroblasts or undifferentiated pluripotent stem cells.

15. The composition of claim 1 , wherein the cardiomyocytes are cryopreserved cardiomyocytes.

Assignments (2)
CHANGE OF NAME Recorded May 3, 2018
From: CELLULAR DYNAMICS INTERNATIONAL, INC.
To: FUJIFILM CELLULAR DYNAMICS, INC.
Reel/Frame 046069/0525 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2011
From: MEYER, NATHAN; SWANSON, BRAD; FIENE, STEVE
To: CELLULAR DYNAMICS INTERNATIONAL, INC.
Reel/Frame 026855/0238 →
Continuity (3)
Provisional Application 61356136 · Jun 18, 2010
Provisional Application 61356916 · Jun 21, 2010
Related Publication 20110312090A1 · Dec 22, 2011